U.S. markets closed

NeuroMetrix, Inc. (NURO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
11.34+0.46 (+4.23%)
At close: 4:00PM EDT
Sign in to post a message.
  • K
    aTyr Pharma, Inc.
    Easy to borrow stock, relatively cheap, got squeezed hard. remindes me on $NURO. I am expecting to be squeezed more in the premarket, then couple circuit halts and then fail follow through all day. The other scenario it will sell off at the open especially if they do offering.
  • F
    It will explode anytime
    Just hold your shares
    Especially those who bought in 15-19 range
    Don't panic sell!
  • J
    For you Seth klarman fans I want to offer you all some perspective on NURO. If they can sell to 2 percent of the fibromyalgia cases a year in the developed world they can generate 100 million in revenue. The stock is trading at $25, at less than a 100 million dollar valuation. They have 8 million in cash for development. They just received breakthrough FDA designation. 2 percent of the year cases is all they need for a 100 fricking million in revenue. This is a margin of safety play. Buy. Nevermind the 37 percent short with a float that is 20x less than GME, if the wallstreetbets crowd pumps this it will be at 89 bucks in no time.
  • G
    A common Covid symptom is pain in various parts of the body. Perhaps NURO's products can address this problem? Thoughts?
  • M
    Im predicting a little Squeeze up to 45+ on Monday with a little buypressure and volume.
  • E
    My Fellow Americans: "Be Big" tomorrow and buy BBIG stock. BBIG could very well open at $12.50 and close at $25+ tomorrow. Here's why:

    - BBIG short volume 73M
    - Short borrow fee rate 62.06%
    - No shares available to short (even by Fidelity)
    - Fundamentals reveal it's a solid NFT and merger investment
    - Evidence from Friday that the squeeze is only beginning
  • b
    I add more today good luck guys hope will get good return
  • U
    $15 by Friday
  • A
    I Been averaging down Nuro. Thank God I did. Someting is up. I don't know what it is but last time it went up after hours like this it went to $38 dollars 😍 let's go to $78 why not! I'm gonna hold some of my stocks no matter what because I do believe in this company and their product but seeing green makes me very happy!! It's about time! Let's Go Nuro it's out turn 🙏🙏👏👏🎉❤️
  • P
    I am down 72% on this one. 🥴
  • Z
    Neurometrix Inc (NURO) Senior Vice President, CFO Thomas T Higgins Sold $527,500 of Shares
  • y
    I have been watching this for a while, paying particular attention to short volume. After the last run to the $20/sh, 700k more shares were shorted during that spike. Then followed by more shorting and selling to where it is after 15 days. My speculation is that the shorted shares is north of 1.5 million out of 5 million which puts it at 30%. The company has not issued any news since the fibromyalgia. I am still on the sideline....
  • D
    Is it too late to buy in?

    Is it done squeezing?
  • M
    My average price just went up; could see a nice payoff tomorrow morning.
  • M
    FWIW -I trimmed my position way down after hours Friday. This is a long play -earnings won't report for 2 months, FDA is likely still specing out the final study, and the approval is still 8 months out. The company filed to sell shares -that might have happened friday -so wed we would see SEC. If the company exercised it's buy, and there are still no shares to borrow, that is a clear short squeeze flag!
    On the other hand, this FM device is only $200 -if I suffered, I would just buy now! $200 is what it costs to see a doctor shrug his shoulders!
    The very short term (8/30) 10:30ET there are no shares available to borrow -if this could squeeze again!
  • P
    Purple Rhino
    I'm so in the red on this it will take forever to see green again. Nuroed!
  • t
    They had some interesting insights about NURO on (http://Rightpicker.com). Definitely made me think twice about the company.
  • F
    Nuro train 🤣
  • P
    Looks like Reddit Attacked !!! Let’s go !!!
  • A
    Abu Loay
    $STAF conversation
    Staffing 360 Solutions Stock Pops After Q3, Q4 Outlook In Shareholder Letter
    Benzinga · 08/27/2021 15:26
    Staffing 360 Solutions Inc (NASDAQ:STAF) released a letter to shareholders from Brendan Flood, Chairman, CEO, and President.
    The management highlights improved Q2 results with revenue growth of 23% and gross profit grew 37% (excluding the disposed business) compared to last year.
    It reduced non-receivables debt and redeemable preference shares from $72.3 million (81%) to $13.5 million - decreasing the interest burden by more than $3.6 million per annum.
    The company's proceeds from the most recent financing are to be used for working capital purposes. In particular, a portion of these funds earmarked for expanding temporary contractor payroll from September onwards.
    The management expects Q3 operating results to exceed Q2, and that Q4 should show further improvement over Q3. It also anticipates achieving positive net income by the end of Q4.
    Organic growth in six operating brands is enhanced by expanding geographic footprint into new regions and increasing cross-sales between brands.
    Staffing 360 Solutions' goal is to grow organically and through select accretive M&A transactions to achieve sustainable, profitable growth to a $500 million revenue company over the next two years.
    Price Action: STAF shares traded higher by 9.79% at $2.02 on the last check Friday.